These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 15071248)

  • 41. Diagnostic capabilities of devices for cardiac resynchronization therapy.
    Gardini A; Lupo P; Zanelli E; Bisetti S; Cappato R
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):186-9. PubMed ID: 19829134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specificity of atrial mode switching in detecting atrial fibrillation episodes: roles of length and contiguity.
    De Simone A; Senatore G; Turco P; Vitale DF; Romano E; Stabile G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S47-9. PubMed ID: 15683523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paradoxical atrial undersensing due to inappropriate atrial noise reversion of atrial fibrillation in dual-chamber pacemakers.
    Kolb C; Halbfass P; Zrenner B; Schmitt C
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):696-700. PubMed ID: 16050825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of far-field R wave sensing for the avoidance of inappropriate mode switch in dual chamber pacemakers: results of the FFS-test study.
    Kolb C; Wille B; Maurer D; Schuchert A; Weber R; Schibgilla V; Klein N; Hümmer A; Schmitt C; Zrenner B;
    J Cardiovasc Electrophysiol; 2006 Sep; 17(9):992-7. PubMed ID: 16948743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of bipole tip-to-ring distance in atrial electrodes upon atrial tachyarrhythmia sensing capability in modern dual-chamber pacemakers.
    Silberbauer J; Arya A; Veasey RA; Boodhoo L; Kamalvand K; O'Nunain S; Hildick-Smith D; Paul V; Patel NR; Lloyd GW; Sulke N
    Pacing Clin Electrophysiol; 2010 Jan; 33(1):85-93. PubMed ID: 19889192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recording atrial monophasic action potentials using standard pacemaker leads: an alternative way to study electrophysiology properties of the human atrium in vivo?
    Christ T; Rauwolf T; Braun M; Dobrev D; Ravens U; Strasser RH
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1632-7. PubMed ID: 15613126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The reliability of computer-assisted long-term ECG analysis of pacemaker malfunction in patients with ventricular demand pacemakers].
    Brandes A; Gonska BD; Distler WK; Diederich KW; Bethge KP
    Z Kardiol; 1994 May; 83(5):351-8. PubMed ID: 8053244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heart rate variability measures during sinus rhythm predict cycle length entropy during atrial fibrillation.
    Segerson NM; Smith ML; Wasmund SL; Lux RL; Daccarett M; Hamdan MH
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1031-6. PubMed ID: 18462335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Septal atrial pacing for the prevention of atrial fibrillation.
    Hakacova N; Velimirovic D; Margitfalvi P; Hatala R; Buckingham TA
    Europace; 2007 Dec; 9(12):1124-8. PubMed ID: 18024494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Device treatment of atrial tachycardia--minor additional effect of repeating pacing sequences.
    Schuster P; Faerestrand S; Ohm OJ
    Int J Cardiol; 2005 Sep; 104(1):10-4. PubMed ID: 16137503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: the Study of Atrial Fibrillation Reduction (SAFARI).
    Gold MR; Hoffmann E;
    Am Heart J; 2006 Aug; 152(2):231-6. PubMed ID: 16875902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitachycardia pacing therapies and arrhythmia monitoring diagnostics for the treatment of atrial fibrillation.
    Gillis AM; Morck M; Fitts S
    Can J Cardiol; 2002 Sep; 18(9):992-5. PubMed ID: 12368934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reliability of a new algorithm for automatic mode switching from DDDR to DDIR pacing mode in sinus node disease patients with chronotropic incompetence and recurrent paroxysmal atrial fibrillation.
    Ricci R; Puglisi A; Azzolini P; Spampinato A; Pignalberi C; Bellocci F; Adinolfi E; Dini P; Cavaglià S; De Seta F
    Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1719-23. PubMed ID: 8945030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of pacemaker and defibrillator therapy for the treatment of atrial fibrillation.
    Mitchell AR
    Minerva Cardioangiol; 2004 Apr; 52(2):141-53. PubMed ID: 15194995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: the atrial fibrillation detect study.
    Ciconte G; Saviano M; Giannelli L; Calovic Z; Baldi M; Ciaccio C; Cuko A; Vitale R; Giacopelli D; Conti M; Lipartiti F; Giordano F; Maresca F; Moscatiello M; Vicedomini G; Santinelli V; Pappone C
    Europace; 2017 Jul; 19(7):1101-1108. PubMed ID: 27702865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device.
    Martinek M; Aichinger J; Nesser HJ; Ziegler PD; Purerfellner H
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):818-23. PubMed ID: 17573835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ambulatory ECG monitoring in atrial fibrillation management.
    Rosero SZ; Kutyifa V; Olshansky B; Zareba W
    Prog Cardiovasc Dis; 2013; 56(2):143-52. PubMed ID: 24215746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.